Doctor Xiaopei Cui

Shandong University Qilu Hospital, Jinan (China)

Membership: ESC Professional Member

Follow

Contributor content

Efficacy and safety of selexipag based triple combination targeted drug therapy in chinese patients with pulmonary arterial hypertension

Presentation

Efficacy and safety of selexipag based triple combination targeted drug therapy in chinese patients with pulmonary arterial hypertension

ESC 365 is supported by

novartis

Explore sponsored resources